Report cover image

Biomaterials Market Growth, Size, Industry Trend Analysis, and Forecast 2024 - 2032

Publisher Acumen Research and Consulting
Published Feb 01, 2025
Length 250 Pages
SKU # ACRC19682526

Description

The Global Biomaterials Market Size accounted for USD 170.5 Billion in 2023 and is estimated to achieve a market size of USD 589.5 Billion by 2032 growing at a CAGR of 14.9% from 2024 to 2032.

The biomaterials market has been a critical sector in the broader healthcare and medical device industries, playing a significant role in the development of advanced medical treatments and technologies. Biomaterials are natural or synthetic materials designed to interact with biological systems for medical purposes, including the replacement, repair, or enhancement of biological functions. These materials are used in a wide range of applications, including orthopedic implants, cardiovascular devices, dental implants, wound healing, drug delivery systems, and tissue engineering. The increasing demand for improved medical solutions, advancements in biomaterials technology, and growing awareness of personalized medicine are driving the growth of the biomaterials market. This abstract explores the key growth drivers, technological innovations, challenges, and regional dynamics that are shaping the future of the biomaterials market.

Biomaterials Market Segmentation

The worldwide market for biomaterials is split based on type, application, and geography.

Biomaterial Market By Type

Metallic
Polymeric
Ceramic
Natural

Biomaterial Market By Application

Dental
Orthopedic
Cardiovascular
Wound Healing
Plastic Surgery
Ophthalmology
Tissue Engineering
Neurological Disorders
Drug-Delivery Systems

Regional Insights

Regionally, North America holds the largest share of the biomaterials market, driven by advanced healthcare infrastructure, significant investment in research and development, and the high prevalence of chronic diseases. The U.S., in particular, is a key player in the development and commercialization of advanced biomaterials, thanks to its robust pharmaceutical and medical device industries.

Europe is another prominent market for biomaterials, with strong growth driven by the aging population and an increasing demand for personalized healthcare solutions. The European Union’s focus on healthcare innovation and the growing number of research collaborations have supported the development of new biomaterials.

The Asia-Pacific region is expected to witness the highest growth rate in the coming years, driven by the increasing healthcare expenditure, growing medical tourism, and rising demand for advanced biomaterials. Countries like China, India, and Japan are emerging as key players in the global biomaterials market due to their expanding healthcare infrastructure and rising adoption of advanced medical technologies.

Biomaterials Market Players

Some of the top biomaterials companies offered in our report includes Stryker, Evonik Industries AG, CoorsTek Inc., Medtronic, Dentsply Sirona, BASF SE, Carpenter Technology Corporation, Zimmer Biomet Holdings, Inc., Invibio Ltd., Johnson & Johnson, Covalon Technologies Ltd., and Berkeley Advanced Biomaterials.

Conclusion

The biomaterials market is poised for significant growth, driven by the increasing demand for advanced medical solutions, technological innovations, and the rising prevalence of chronic diseases. Advancements in materials science, nanotechnology, and 3D printing are opening up new possibilities for the development of highly effective and personalized biomaterials. Despite challenges such as high development costs and regulatory hurdles, the market is expected to expand as the demand for regenerative medicine and minimally invasive procedures grows. With its potential to revolutionize various medical applications, the biomaterials market will continue to play a critical role in advancing healthcare worldwide.

Table of Contents

250 Pages
CHAPTER 1. Industry Overview of Biomaterials Market
1.1. Definition and Scope
1.1.1. Definition of Biomaterials
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Biomaterials Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Biomaterials Market By Type
1.2.3. Biomaterials Market By Application
1.2.4. Biomaterials Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Biomaterials Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Biomaterials Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2023
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2023
4.2. R&D Status of Major Manufacturers in 2023
CHAPTER 5. Biomaterials Market By Type
5.1. Introduction
5.2. Biomaterials Revenue By Type
5.2.1. Biomaterials Revenue (USD Million) and Forecast, By Type, 2020-2032
5.2.2. Metallic
5.2.2.1. Metallic Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3. Polymeric
5.2.3.1. Polymeric Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.4. Ceramic
5.2.4.1. Ceramic Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.5. Natural
5.2.5.1. Natural Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 6. Biomaterials Market By Application
6.1. Introduction
6.2. Biomaterials Revenue By Application
6.2.1. Biomaterials Revenue (USD Million) and Forecast, By Application, 2020-2032
6.2.2. Dental
6.2.2.1. Dental Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.3. Orthopedic
6.2.3.1. Orthopedic Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.4. Cardiovascular
6.2.4.1. Cardiovascular Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.5. Wound Healing
6.2.5.1. Wound Healing Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.6. Plastic Surgery
6.2.6.1. Plastic Surgery Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.7. Ophthalmology
6.2.7.1. Ophthalmology Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.8. Tissue Engineering
6.2.8.1. Tissue Engineering Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.9. Neurological Disorders
6.2.9.1. Neurological Disorders Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.10. Drug-Delivery Systems
6.2.10.1. Drug-Delivery Systems Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 7. North America Biomaterials Market By Country
7.1. North America Biomaterials Market Overview
7.2. U.S.
7.2.1. U.S. Biomaterials Revenue (USD Million) and Forecast By Type, 2020-2032
7.2.2. U.S. Biomaterials Revenue (USD Million) and Forecast By Application, 2020-2032
7.3. Canada
7.3.1. Canada Biomaterials Revenue (USD Million) and Forecast By Type, 2020-2032
7.3.2. Canada Biomaterials Revenue (USD Million) and Forecast By Application, 2020-2032
7.4. North America PEST Analysis
CHAPTER 8. Europe Biomaterials Market By Country
8.1. Europe Biomaterials Market Overview
8.2. U.K.
8.2.1. U.K. Biomaterials Revenue (USD Million) and Forecast By Type, 2020-2032
8.2.2. U.K. Biomaterials Revenue (USD Million) and Forecast By Application, 2020-2032
8.3. Germany
8.3.1. Germany Biomaterials Revenue (USD Million) and Forecast By Type, 2020-2032
8.3.2. Germany Biomaterials Revenue (USD Million) and Forecast By Application, 2020-2032
8.4. France
8.4.1. France Biomaterials Revenue (USD Million) and Forecast By Type, 2020-2032
8.4.2. France Biomaterials Revenue (USD Million) and Forecast By Application, 2020-2032
8.5. Spain
8.5.1. Spain Biomaterials Revenue (USD Million) and Forecast By Type, 2020-2032
8.5.2. Spain Biomaterials Revenue (USD Million) and Forecast By Application, 2020-2032
8.6. Rest of Europe
8.6.1. Rest of Europe Biomaterials Revenue (USD Million) and Forecast By Type, 2020-2032
8.6.2. Rest of Europe Biomaterials Revenue (USD Million) and Forecast By Application, 2020-2032
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific Biomaterials Market By Country
9.1. Asia Pacific Biomaterials Market Overview
9.2. China
9.2.1. China Biomaterials Revenue (USD Million) and Forecast By Type, 2020-2032
9.2.2. China Biomaterials Revenue (USD Million) and Forecast By Application, 2020-2032
9.3. Japan
9.3.1. Japan Biomaterials Revenue (USD Million) and Forecast By Type, 2020-2032
9.3.2. Japan Biomaterials Revenue (USD Million) and Forecast By Application, 2020-2032
9.4. India
9.4.1. India Biomaterials Revenue (USD Million) and Forecast By Type, 2020-2032
9.4.2. India Biomaterials Revenue (USD Million) and Forecast By Application, 2020-2032
9.5. Australia
9.5.1. Australia Biomaterials Revenue (USD Million) and Forecast By Type, 2020-2032
9.5.2. Australia Biomaterials Revenue (USD Million) and Forecast By Application, 2020-2032
9.6. South Korea
9.6.1. South Korea Biomaterials Revenue (USD Million) and Forecast By Type, 2020-2032
9.6.2. South Korea Biomaterials Revenue (USD Million) and Forecast By Application, 2020-2032
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Biomaterials Revenue (USD Million) and Forecast By Type, 2020-2032
9.7.2. Rest of Asia-Pacific Biomaterials Revenue (USD Million) and Forecast By Application, 2020-2032
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Biomaterials Market By Country
10.1. Latin America Biomaterials Market Overview
10.2. Brazil
10.2.1. Brazil Biomaterials Revenue (USD Million) and Forecast By Type, 2020-2032
10.2.2. Brazil Biomaterials Revenue (USD Million) and Forecast By Application, 2020-2032
10.3. Mexico
10.3.1. Mexico Biomaterials Revenue (USD Million) and Forecast By Type, 2020-2032
10.3.2. Mexico Biomaterials Revenue (USD Million) and Forecast By Application, 2020-2032
10.4. Rest of Latin America
10.4.1. Rest of Latin America Biomaterials Revenue (USD Million) and Forecast By Type, 2020-2032
10.4.2. Rest of Latin America Biomaterials Revenue (USD Million) and Forecast By Application, 2020-2032
10.5. Latin America PEST Analysis
CHAPTER 11. Middle East & Africa Biomaterials Market By Country
11.1. Middle East & Africa Biomaterials Market Overview
11.2. GCC
11.2.1. GCC Biomaterials Revenue (USD Million) and Forecast By Type, 2020-2032
11.2.2. GCC Biomaterials Revenue (USD Million) and Forecast By Application, 2020-2032
11.3. South Africa
11.3.1. South Africa Biomaterials Revenue (USD Million) and Forecast By Type, 2020-2032
11.3.2. South Africa Biomaterials Revenue (USD Million) and Forecast By Application, 2020-2032
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Biomaterials Revenue (USD Million) and Forecast By Type, 2020-2032
11.4.2. Rest of Middle East & Africa Biomaterials Revenue (USD Million) and Forecast By Application, 2020-2032
11.5. Middle East & Africa PEST Analysis
CHAPTER 12. Player Analysis Of Biomaterials Market
12.1. Biomaterials Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global Biomaterials Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 13. Company Profile
13.1. Stryker
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (USD Million), 2023
13.1.3.2. Stryker 2023 Biomaterials Business Regional Distribution
13.1.4. Product /Service and Specification
13.1.5. Recent Developments & Business Strategy
13.2. Evonik Industries AG
13.3. CoorsTek Inc.
13.4. Medtronic
13.5. Dentsply Sirona
13.6. BASF SE
13.7. Carpenter Technology Corporation
13.8. Zimmer Biomet Holdings, Inc.
13.9. Invibio Ltd.
13.10. Johnson & Johnson
13.11. Covalon Technologies Ltd.
13.12. Berkeley Advanced Biomaterials

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us